Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants.
J Virol
; 95(19): e0068521, 2021 09 09.
Article
in En
| MEDLINE
| ID: mdl-34287040
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Angiotensin-Converting Enzyme 2
/
SARS-CoV-2
/
Antibodies, Viral
Limits:
Humans
Language:
En
Journal:
J Virol
Year:
2021
Document type:
Article
Affiliation country:
United kingdom
Country of publication:
United States